Molecular Mechanism of Yangshen Maidong Decoction in the Treatment of Chronic Heart Failure based on Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulations-Reference-Cited by-同舟云学术

Molecular Mechanism of Yangshen Maidong Decoction in the Treatment of Chronic Heart Failure based on Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulations

Published:2024-05-16 Issue:2 Volume:82 Page:1433-1451
ISSN:1085-9195
Container-title:Cell Biochemistry and Biophysics
language:en
Short-container-title:Cell Biochem Biophys

Author:

Cheng Wei,Zhang Bo-Feng,Chen Na,Liu Qun,Ma Xin,Fu Xiao,Xu Min

Funder

National Administration of Traditional Chinese Medicine

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s12013-024-01297-7.pdf

Reference106 articles.

1. Chen, L., Wei, N. & Jiang, Y. et al. (2023). Comparative pharmacokinetics of seven bioactive components after oral administration of crude and processed Qixue Shuangbu Prescription in chronic heart failure rats by microdialysis combined with UPLC-MS/MS. Journal of Ethnopharmacology, 303, 116035.

2. Zhang, H., Zhang, L. & Yin, K. et al. (2023). Analysis of function role and long noncoding RNA expression in chronic heart failure rats treated with Hui Yang Jiu Ji decoction. Journal of Healthcare Engineering, 2023, 7438567.

3. Gheorghiade, M., Abraham, W. T., & Albert, N. M., et al. (2006). Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA, 296(18), 2217–2226.

4. West, R., Liang, L. & Fonarow, G. C. et al. (2011). Characterization of heart failure patients with preserved ejection fraction: a comparison between ADHERE-US registry and ADHERE-International registry. European Journal of Heart Failure, 13(9), 945–952.

5. Towbin, J. A. (2014). Inherited cardiomyopathies. Circulation Journal, 78(10), 2347–2356.